Abstract
Objectives: Sampling of both the cervix and urine increases the chance of detection of Chlamydia trachomatis compared with sampling either site alone. We determined the effect of combining urine and cervical swab specimens in the clinic setting on the sensitivity of C trachomatis polymerase chain reaction (PCR) testing.
Methods: For each of 100 women attending a genitourinary medicine clinic with high likelihood of genital C trachomatis infection, one endocervical swab was placed in transport medium and another in one of two aliquots of first void urine. Four PCR assays per patient (urine + swab, swab alone, and urine alone both pre- and post-freeze-thawing) were processed by automated C trachomatis PCR (Cobas, Amplicor). An inhibition control was included with each assay to identify specimens containing PCR inhibitors.
Results: 71% of women were Amplicor C trachomatis PCR positive (according to the results of at least one specimen). PCR test results were concordant for 95/100 patients, and of the five discordant result sets there was only one major discrepancy. Inhibitors of PCR were present in 22/400 specimens from 20 patients, and 16/22 were cervical swabs (p<0.001).
Conclusions: Combining a cervical swab with a urine specimen is acceptable for PCR testing for genital C trachomatis infection, and has the potential to increase further the cost effectiveness of DNA based screening for C trachomatis genital infection.
Key Words: polymerase chain reaction; Chlamydia trachomatis
Full Text
The Full Text of this article is available as a PDF (69.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Howell M. R., Quinn T. C., Brathwaite W., Gaydos C. A. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis. 1998 Feb;25(2):108–117. doi: 10.1097/00007435-199802000-00008. [DOI] [PubMed] [Google Scholar]
- Mahony J., Chong S., Jang D., Luinstra K., Faught M., Dalby D., Sellors J., Chernesky M. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol. 1998 Nov;36(11):3122–3126. doi: 10.1128/jcm.36.11.3122-3126.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quinn T. C., Welsh L., Lentz A., Crotchfelt K., Zenilman J., Newhall J., Gaydos C. Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol. 1996 Jun;34(6):1401–1406. doi: 10.1128/jcm.34.6.1401-1406.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor-Robinson D., Robinson A. J. DNA methods should be used to detect Chlamydia trachomatis. BMJ. 1998 Nov 28;317(7171):1525–1525. doi: 10.1136/bmj.317.7171.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Toye B., Woods W., Bobrowska M., Ramotar K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J Clin Microbiol. 1998 Aug;36(8):2356–2358. doi: 10.1128/jcm.36.8.2356-2358.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verkooyen R. P., Luijendijk A., Huisman W. M., Goessens W. H., Kluytmans J. A., van Rijsoort-Vos J. H., Verbrugh H. A. Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol. 1996 Dec;34(12):3072–3074. doi: 10.1128/jcm.34.12.3072-3074.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]